Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China · Delayed Price · Currency is CNY 16.23
-0.16 (-0.98%)
At close: Feb 13, 2026
SHA:688526 Market Cap
SHA:688526 has a market cap or net worth of 7.53 billion as of February 13, 2026. Its market cap has increased by 24.72% in one year.
Market Cap
7.53B
Enterprise Value
5.82B
Revenue
1.01B
Ranking
n/a
PE Ratio
16.57
Stock Price
16.23
Market Cap Chart
Since September 22, 2020, SHA:688526's market cap has decreased from 14.68B to 7.53B, a decrease of -48.73%. That is a compound annual growth rate of -11.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 7.53B | 6.36% |
| Dec 31, 2025 | 7.08B | 6.68% |
| Dec 31, 2024 | 6.64B | -30.15% |
| Dec 29, 2023 | 9.50B | -9.03% |
| Dec 30, 2022 | 10.44B | -18.45% |
| Dec 31, 2021 | 12.81B | -33.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anhui Huaheng Biotechnology | 8.55B |
| Acrobiosystems | 8.35B |
| Nanjing Vazyme Biotech | 8.26B |
| Zhejiang Ausun Pharmaceutical | 8.05B |
| Suzhou Fengbei Biotech Stock | 7.86B |
| R&G PharmaStudies | 7.43B |
| Jiangsu Aidea Pharmaceutical Group | 7.36B |
| Shenzhen Weiguang Biological Products | 7.00B |